Macawaris, Ameer S.
HRN: 21-35-60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2022
AMPICILLIN 250MG (VIAL)
05/31/2022
06/08/2022
IV
145 Mg
Q12Hrs
PSNB Secondary To Maternal UTI
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes